Monoclonal antibodies specific to in vivo fragments derived from fibrinogen
CA 1248472 A · Owner: New York Blood Center, Inc. · Inventors: Wiebe, Michael E.; Kudryk, Bohdan J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Hybridoma for production of monoclonal antibody to an antigen found on the peptide fragment of the B.beta. chain of human fibrinogen or fibrin I containing amino acid residues 1-42. The hybridoma is formed by fusing an animal myeloma cell, e.g. a mouse myeloma cell, with a splenocyte from an animal, e.g. a mouse, immunized with an NH2-terminal of human fibrinogen or fibrin.I. Hybridoma for production of monoclonal antibody to an antigen found on the peptide fragment of the B.beta. chain of human fibrin I1 containing amino acid residues 15-42. The hybridoma is formed by fusing an animal, e.g. mouse myeloma cell with a splenocyte from an animal, e.g. mouse, immunized with a NH2-terminal of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted January 10, 1989. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended January 10, 2006.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.